San Francisco, CA, United States of America

Ronald Kenichi Yamamoto

This inventor holds 44 USPTO granted patents and 23 published patent applications, plus 1 CIPO patent and 10 EPO patents, primarily in Ophthalmic Devices. Top assignees: Vitaphore Corporation, Iscience Interventional Corporation, Point Biomedical Corporation. Active years: 1987-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald Kenichi Yamamoto. Retrieved from https://idiyas.com/inventor/ronald-kenichi-yamamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 44 

% Patents Active = 81.8


 

Average Co-Inventor Count = 2.9

ph-index = 26

Forward Citations = 3,219(Granted Patents)


Location History:

  • Redwood City, CA (US) (1987 - 1990)
  • San Francisco, CA (US) (1994 - 2024)

Company Filing History:


Years Active: 1987-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Ocular Injector
Ophthalmic Delivery Device
Subretinal Access Device
Treatment of Ocular Disease
Intravesical Drug Delivery
Microparticles
Tissue Repair Matrix
Bone Grafting Matrix
Hydrogel-Based Microsphere
Muco-Adhesive Polymers
Expandable Catheter
Surgical Bypass
44 patents (USPTO):Explore Patents

Title: Innovations of Ronald Kenichi Yamamoto: Pioneering Ocular Access Technologies

Introduction

Ronald Kenichi Yamamoto, based in San Francisco, CA, is a prominent inventor with an impressive portfolio of 44 patents to his name. His work primarily focuses on advanced medical technologies, specifically in the field of ocular access devices. Yamamoto’s innovations aim to enhance medical procedures related to the eye, enabling safer and more effective treatments.

Latest Patents

Among his latest inventions, Yamamoto has developed a groundbreaking device for ocular access. This invention provides innovative ways to access the suprachoroidal space or sub-retinal space within the eye using a minimally invasive transconjunctival approach. The design allows for usage after partial dissection of the outer scleral layer, enabling medical professionals to effectively reach these critical areas of the eye.

Another notable patent by Yamamoto is an ocular injector that facilitates drug delivery directly to the suprachoroidal space (SCS) of the eye. This method involves inserting a puncture member to create a pathway through which a flexible cannula is advanced. With its atraumatic distal tip, the flexible cannula allows for the precise administration of therapeutic substances, demonstrating a significant advancement in ocular medical procedures.

Career Highlights

Throughout his career, Ronald Kenichi Yamamoto has contributed substantially to the medical and technology sectors. He has held pivotal roles at notable companies such as Vitaphore Corporation and Iscience Interventional Corporation, where he has focused on developing innovative solutions that enhance patient care and treatment outcomes.

Collaborations

Yamamoto has collaborated with other esteemed professionals in the field, including Stanley R. Conston and Thomas B. Ottoboni. These collaborations have contributed to the development and refinement of his innovative ideas, furthering the advancement of ocular access technologies.

Conclusion

Ronald Kenichi Yamamoto's dedication to innovation in ocular access technologies highlights the significant impact of inventors in the medical field. With his numerous patents and collaborative efforts, he continues to pave the way for new methods that improve the safety and effectiveness of eye treatments, positioning himself as a leading figure in the realm of medical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…